Found: 6
Select item for more details and to access through your institution.
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Mott cells in CD20-positive myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Other
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 3, p. 326, doi. 10.1111/j.1365-2141.2010.08250.x
- By:
- Publication type:
- Article
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17626-2
- By:
- Publication type:
- Article
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27270-z
- By:
- Publication type:
- Article